Adiponectin, type 2 diabetes and cardiovascular risk

Conclusions
In conclusion, increasing plasma adiponectin is associated with decreased risk of T2DM and subsequently reduced risk of CV events.

Source: European Journal of Preventive Cardiology - February 10, 2015 Category: Cardiology Authors: Lindberg, S., Jensen, J. S., Bjerre, M., Pedersen, S. H., Frystyk, J., Flyvbjerg, A., Galatius, S., Jeppesen, J., Mogelvang, R. Tags: Original scientific paper Source Type: research